BioHarvest Sciences (BHST) Projected to Post Quarterly Earnings on Tuesday

BioHarvest Sciences (NASDAQ:BHST - Get Free Report) is expected to be issuing its Q4 2024 quarterly earnings data before the market opens on Tuesday, April 29th. Analysts expect BioHarvest Sciences to post earnings of ($0.12) per share and revenue of $7.80 million for the quarter.

BioHarvest Sciences (NASDAQ:BHST - Get Free Report) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by ($0.05). The business had revenue of $7.17 million during the quarter, compared to the consensus estimate of $7.24 million. On average, analysts expect BioHarvest Sciences to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

BioHarvest Sciences Stock Down 0.8 %

Shares of BHST traded down $0.05 during mid-day trading on Monday, reaching $6.50. 1,303 shares of the company's stock were exchanged, compared to its average volume of 18,095. The stock's fifty day simple moving average is $5.77. BioHarvest Sciences has a 52-week low of $6.50 and a 52-week high of $7.38. The stock has a market cap of $106.76 million, a PE ratio of -5.20 and a beta of 0.84.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a "buy" rating and issued a $14.00 price objective on shares of BioHarvest Sciences in a research note on Tuesday, April 8th.

About BioHarvest Sciences

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.